Today

Agents

Chat

Arena

Discover

More

App

Kimberly-Clark Q2 Adjusted EPS USD 2.12 Vs. IBES Estimate USD 2.01 - KMB News | Rallies

Kimberly-Clark Q2 Adjusted EPS USD 2.12 Vs. IBES Estimate USD 2.01

KMB•2026-08-04

Kimberly-Clark reports second-quarter results

Kimberly-Clark Q2 sales USD 4,189 million vs. IBES estimate USD 4,221 million.

Q2 EPS USD 1.04
Q2 gross margin 38.3%

Related News

Pfizer Q2 results beat; raises 2026 revenue outlook

PFE•2026-08-04

Rhythm Pharmaceuticals Q2 net loss narrows on US launch demand

RYTM•2026-08-04

Blackstone Digital Infrastructure Trust publishes updated investor presentation on website

2026-08-04

Westlake Chemical Partners' Q2 net income dips

WLKP•2026-08-04

Timken Q2 sales beat on higher volumes and pricing

TKR•2026-08-04